Supplementary Figure S7 from Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma

Authors: Kai Yu, Rebecca S. Tidwell, Tharakeswara K. Bathala et al.
Publication:
Published: Unknown date
Source: Crossref
Back to Search View Original Cite This Article

Abstract

<jats:p>&lt;p&gt;Longitudinal TME cell changes during trial therapy.&lt;/p&gt;</jats:p>

Keywords

plongitudinal cell changes trial therapyp

Related Articles

Co-occurrence networks from BRUVS, uncovering fish assemblage structure using image co detections

João Guerreiro - Unknown

Read More
ENVIRONMENTAL AND OCCUPATIONAL EXPOSURE MIXTURES IN PARKINSON’S DISEASE AND PARKINSONISM: GEOSPATIAL, BIOMONITORING, AND MULTI-OMICS EVIDENCE FROM A MATCHED CASE-CONTROL STUDY

Lewis, Freeman - Unknown

Read More
Is social housing policy failing NZ families trying to move from renting to home ownership?

Simon Opit - Unknown

Read More
Social Risk and Needs Assessment in Miami-Dade County: Preliminary Findings from a Comprehensive Community Health Survey

Desgrottes, Naika, Clarke, Rachel D. et al. - Unknown

Read More
&lt;i&gt;Bostrychia edisondepaulae &lt;/i&gt;(Rhodophyta, Rhodomelaceae), a new freshwater species from Brazil

Orlando Necchi Jr, John A. West et al. - Unknown

Read More
Journal Ideas PyMinds Charcha More
PORE

About

About Us

Resources

Help Centre Research Guides CiteScore

Legal

Terms of Service Privacy Policy Cookie Policy Accessibility

Connect

Contact Us
© 2026 PORE. Content available under CC BY-NC 4.0